Newsbenzinga
Alkermes Says Lead Drug Maintains Wakefulness Benefits in Long-Term Narcolepsy Study
· Published
Article summary
Alkermes reports positive long-term data for alixorexton, showing sustained wakefulness and symptom improvements in NT1 and NT2 narcolepsy.
An excerpt from the original article.
Comments —
Loading comments…